Raymond James Financial Services Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.97M | Buy |
|
|||||
|
2024
Q2 | $534K | Sell |
|
|||||
|
2024
Q1 | $464K | Buy |
|
|||||
|
2023
Q4 | $440K | Sell |
|
|||||
|
2023
Q3 | $414K | Sell |
|
|||||
|
2023
Q2 | $452K | Sell |
|
|||||
|
2023
Q1 | $955K | Sell |
|
|||||
|
2022
Q4 | $1.22M | Sell |
|
|||||
|
2022
Q3 | $1.27M | Sell |
|
|||||
|
2022
Q2 | $1.73M | Buy |
|
|||||
|
2022
Q1 | $1.94M | Buy |
|
|||||
|
2021
Q4 | $1.84M | Buy |
|
|||||
|
2021
Q3 | $1.95M | Buy |
|
|||||
|
2021
Q2 | $1.66M | Buy |
|
|||||
|
2021
Q1 | $1.02M | Buy |
|
|||||
|
2020
Q4 | $248K | Buy |
|
|||||
|
2020
Q3 | $247K | Buy |
|
|||||
|
2020
Q2 | $248K | Sell |
|
|||||
|
2020
Q1 | $237K | Buy |
|
|||||
|
2019
Q4 | $249K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $761K | Buy |
|